The Patent Eligibility Restoration Act (PERA) proposes a solution to a complex debate: What can be patented, and when do ...
Pharmaceutical Technology on MSN5d
USPTO grants patent to Vistagen’s neuropathic pain treatmentThe US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...
Of the 118 biologics losing exclusivity over the next decade, only 10% have biosimilars in development, meaning a vast ...
Neurizon (ASX:NUZ) has officially snagged a U.S. patent for its neurodegenerative disease and cancer drug candidate NUZ-001, ...
Key considerations for patent counsel when evaluating potential conflicts of interest, including identifying conflicts between current and former clients, understanding relevant authority, navigating ...
On January 14, 2025, the United States Court of Appeals for the Federal Circuit issued a precedential decision in Lynk Labs, ...
Pennsylvania is home to "Weather Capital of the World" Punxsutawney for its Groundhog Day fame. See what other surprising ...
"Last week the Federal Circuit Court of Appeals in Lynk Labs v. Samsung, decided a prior art issue in one of the thornier ...
Anand Barnabas and Anandan S of De Penning & De Penning explain how businesses with a strong technology and R&D focus can use ...
The Federal Circuit recently addressed a deceptively straightforward question: does a published U.S. patent application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback